Ophthalmology

Omeros Files Application for FDA Approval of Cataract Surgery Drug

Omeros, a clinical stage biopharmaceutical company, has announced that has submitted a new drug application to the FDA for its OMS302, a drug for use during intraocular lens replacement surgery.

Carrie Pallardy

Friday, August 2nd, 2013

Omeros also intends to submit a marketing authorization application to the European Medicines Agency.

More Articles on Ophthalmology:
Global Surgical Ophthalmology Market to be Worth $9B by 2017
Valeant to Reduce Workforce by 15% After Bausch +Lomb Buyout
7 Recent Ophthalmologist Moves

Next Up in Ophthalmology

Parker Cornea breaks ground on ophthalmology ASC

The Parker Cornea Eye Institute has broken ground on a 6,500-square-foot ASC in Birmingham, Ala. The ophthalmology-focused facility will include…

By: Cameron Cortigiano
Thursday, November 20th, 2025
Prism adds Washington eye group to national network

Spokane (Wash.) Eye Clinic has joined Prism Vision Group’s network of affiliated practices. The affiliation expands Prism’s geographic reach beyond…

By: Sophie Eydis
Thursday, November 6th, 2025
Bascom Palmer Eye Institute to open 1st international facility

Bascom Palmer Eye Institute, part of UHealth – University of Miami Health System, is opening a facility in Abu Dhabi,…

By: Cameron Cortigiano
Thursday, October 30th, 2025

Comments are closed.

Healthcare learning reimagined: How AI is reshaping the education + compliance landscape

Next Up in Ophthalmology

Parker Cornea breaks ground on ophthalmology ASC

Prism adds Washington eye group to national network

Bascom Palmer Eye Institute to open 1st international facility

Join the 40,000+ ASC leaders who start their day with Becker's